Evidence map›Paper›PMID 15495129›Full record

SynthesisThe Cochrane database of systematic reviews2004

Antifibrinolytic drugs for acute traumatic injury.

T Coats, I Roberts, H Shakur

Registry-linked trialAbstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02492087 (Prophylactic Use of Topical Tranexamic Acid to Aid Surgical Haemostasis During Caesarean Sections in Parturients With Moderate to High Risk of Bleeding), which is not on this map. Cited by 17 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02492087 phase3unknown statusnot on this mapstarted 2015, after this paper: background citation

Prophylactic Use of Topical Tranexamic Acid to Aid Surgical Haemostasis During Caesarean Sections in Parturients With Moderate to High Risk of Bleeding

TypeinterventionalSponsorDr Meng-Li LeeRan2015 to 2016Enrolled84ConditionsPostpartum HaemorrhageArmsTopical tranexamic acid, Normal saline 0.9%
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 7 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Therapeutic efficacy of tranexamic acid on traumatic brain injury: a systematic review and meta-analysis.Scandinavian journal of trauma, resuscitation and emergency medicine · 2024
    Pooled it
  3. Pooled it
  4. Antifibrinolytic drugs for acute traumatic injury.The Cochrane database of systematic reviews · 2015
    Pooled it
  5. Pooled it
  6. Haemostatic drugs for traumatic brain injury.The Cochrane database of systematic reviews · 2010
    Pooled it
  7. Guideline
  8. Trial
  9. Article
  10. Review
  11. Treatment massive haemoptysis in cystic fibrosis with tranexamic acid.Journal of the Royal Society of Medicine · 2011
    Article
  12. Review
  13. Article
  14. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma.Scandinavian journal of trauma, resuscitation and emergency medicine · 2009
    Review
  15. Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2008
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

T Coats
I Roberts
H Shakur
London School of Hygiene & Tropical Medicine · GBLeicester Royal Infirmary · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUncontrolled bleeding is an important cause of death in trauma victims. Antifibrinolytic treatment has been shown to reduce blood loss following surgery and may also be effective in reducing blood loss following trauma.

objectivesTo quantify the effect of antifibrinolytic drugs in reducing blood loss, transfusion requirement and mortality after acute traumatic injury. SEARCH STRATEGY: We searched the Cochrane Injuries Group's Specialised Register, the Cochrane Central Register of Controlled Trials, MEDLINE, PubMed, EMBASE, Science Citation Index, National Research Register, Zetoc, SIGLE, Global Health, LILACS, and Current Controlled Trials. SELECTION CRITERIA: We included all randomised controlled trials of antifibrinolytic agents (aprotinin, tranexamic acid [TXA] and epsilon-aminocaproic acid) following acute traumatic injury. DATA COLLECTION AND ANALYSIS: The titles and abstracts identified in the electronic searches were screened by two independent reviewers to identify studies that had the potential to meet the inclusion criteria. The full reports of all such studies were obtained. From the results of the screened electronic searches, bibliographic searches, and contacts with experts, two reviewers independently selected trials meeting the inclusion criteria, with any disagreements resolved by consensus. MAIN

resultsTwo studies met the inclusion criteria. The study by Auer (1979), with 20 randomised patients, provided no useable outcome data. The study by McMichan (1982), with 77 randomised patients, was reported in four separate reports. Outcome data were reported for death, the proportion undergoing surgical intervention and the volume of blood transfused. Because of the small number of randomised participants, the estimates for each of these outcomes were highly imprecise. Data on the proportion undergoing re-operation and the proportion receiving blood transfusion were not reported. REVIEWERS'

conclusionsThere is insufficient evidence from randomised controlled trials of antifibrinolytic agents in trauma to either support or refute a clinically important treatment effect. Further randomised controlled trials of antifibrinolytic agents in trauma are required.

Indexed as

Antifibrinolytic AgentsBlood Loss, SurgicalBlood TransfusionHemorrhageHumansRandomized Controlled Trials as TopicWounds and InjuriesAntifibrinolytic Agents

Identifiers

PMID15495129
OpenAlexW4251882755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.